Publication Beamlines Strategic Pillar
フィリップ オコンネル、ジェームス; ロバート ポーター、ジョン; ローソン、アレステア; ジョン ライトウッド、ダニエル; ジェイン ウートン、レベッカ et al. (2022). antibody. Patent Number: JP7159420B2.
マイケル アンドリーフ; 丈 石澤; デイビッド シーマー; サラ ザラビ (2022). How to use imipridon. Patent Number: JP2022520997A.
凱爾西 希微克 高熙爾; 奈傑 帕爾漢 克林頓 華可; 曉寧 趙; 約翰 李本考特 (2022). Antibodies to tigit. Patent Number: TW202210514A.
道格拉斯·乌尔里希 (2022). Electron beam exit window in isotope production. Patent Number: CN110402614B.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.
フィリップ オコンネル、ジェイムズ; Philip O'connell James; フィリップ オコンネル、ジェイムズ; ロバート ポーター、ジョン; Robert Porter John et al. (2021). New TNFα structure for therapeutic use. Patent Number: JP2021109880A.
Andreas Ernst; Sachdev Sidhu; Linda Beatty (2021). Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same. Patent Number: CA3053192C.
Anish SURI; Steven Sheriff; Suzanne Suchard; Aaron YAMNIUK; Stanley Krystek et al. (2021). Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40. Patent Number: US11136406B2.